SKCBY (SKCBY) Stock Price & Analysis
SKCBY (SKCBY) rose 0.00% to USD 7.06 as of June 10, 2026 at 07:37 UTC, according to Nexqual real-time market data.
SKCBY last closed at USD 7.06; the session ranged USD 7.32–7.32 on volume of 1 shares. Market capitalization is $15.37B, with a 52-week range of USD 7.06–7.32 (PNK). Source: Nexqual, June 10, 2026 at 07:37 UTC.
Key Statistics (as of June 10, 2026 at 07:37 UTC)
| Price | USD 7.06 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 7.06 |
| Open | USD 7.32 |
| Day Range | USD 7.32 – 7.32 |
| 52-Week Range | USD 7.06 – 7.32 |
| Volume | 1 shares |
| Market Cap | $15.37B |
| Exchange | PNK |
Technical Analysis (SKCBY)
Nexqual's technical model rates SKCBY "SELL" based on 1 bullish and 5 bearish signals across 124 daily candles, as of June 10, 2026 at 07:37 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 100 (overbought) |
| vs SMA50 | Below (USD 7.06) |
| MACD | 0 (negative) |
Analyst Ratings (SKCBY)
Wall Street analysts rate SKCBY "None", per Nexqual as of June 10, 2026 at 07:37 UTC.
| Consensus Rating | None |
|---|
Earnings (SKCBY)
Source: Nexqual, June 10, 2026 at 07:37 UTC.
Financials & Fundamentals (SKCBY)
| Total Revenue | $200.16B |
|---|---|
| Revenue Growth (YoY) | +12.50% |
| Gross Margin | +0.00% |
| Operating Margin | +23.51% |
| Profit Margin | +21.49% |
| ROE | +2.76% |
| Total Cash | $13.86T |
| Total Debt | $14.02T |
Source: Nexqual, June 10, 2026 at 07:37 UTC.
Financial Health Score (SKCBY)
Nexqual rates SKCBY's overall financial health "Mixed" across five dimensions, as of June 10, 2026 at 07:37 UTC.
| Growth | Strong — Revenue +37% YoY (annual) |
|---|---|
| Profitability | Critical — Gross margin 0% |
| Balance Sheet | Mixed — $13.86T cash vs $14.02T debt |
| Cash Flow | Weak — Operating cash flow -$3.44T |
| Efficiency | Weak — ROE 3%, ROA 0.1% |
Ownership (SKCBY)
| Shares Outstanding | 177.06M |
|---|---|
| Float | 167.37M |
Source: Nexqual, June 10, 2026 at 07:37 UTC.
Leadership (SKCBY)
SKCBY is led by Hiroyuki Shibata (age 68), Chairman, President & CEO, per Nexqual as of June 10, 2026 at 07:37 UTC.
| Chairman, President & CEO | Hiroyuki Shibata (age 68) |
|---|---|
| MD & Director | Takehiko Murotani (age 60) |
| MD & Director | Yuji Takahashi (age 56) |
| MD & Director | Yoshinori Jinno (age 53) |
| MD & Director | Ikuo Sekiguchi (age 53) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| SKSUY | Sekisui Chemical Co. | USD 73.28 | ▲ 0% |
| MIUFY | Mitsubishi HC Capital Inc. | USD 15.8 | ▲ 0% |
| SHMUY | SHIMIZU CORP UNSP ADR EA REPR O | USD 79.26 | ▲ 0% |
| JXHLY | Eneos Holdings Inc. | USD 16.49 | ▲ 5.37% |
| SVNBY | SEVEN BANK LTD SPON ADR EA REPR | USD 14.95 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 07:37 UTC. This page is informational and not investment advice.